Focus
weight loss drug
Data Don’t Show Clear Link Between Weight-Loss Drugs and Suicidal Ideation: FDA
The FDA says Ozempic and Wegovy do not clearly show ties to suicidal ideation; more data is needed to investigate the drugs’ mental health risks.
Safety Concerns Loom as Obesity Drugs Head to Clinical Trials in Kids as Young as 6
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over side effects and long-term health impacts.
Beyond Ozempic: Nature’s 7 Secrets to Weight Loss, Blood Sugar Balance
While Ozempic captures headlines, traditional herbs and spices present compelling alternatives for metabolic health.
FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
